Raju Prasad
Vermögen: 710 972 $ am 31.07.2026
Vermögen: 710 972 $ am 31.07.2026
Raju Prasad is currently Chief Financial & Accounting Officer at CRISPR Therapeutics AG since 2023.
Formerly, Dr. Prasad was a Research Analyst at William Blair & Co. LLC from 2014 to 2023 and a Research Associate at the University of North Carolina at Chapel Hill.
Education includes an undergraduate degree from Rutgers State University of New Jersey, a graduate degree from the University of Delaware, and a doctorate from The University of North Carolina at Charlotte.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.08.2026 | 14’815 ( 0.02% ) | 710 972 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CRISPR THERAPEUTICS AG | Finanzdirektor/CFO | 14.03.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.03.2023 |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen